Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly versus three-weekly docetaxel in women with breast cancer
ISRCTN09184069Phase 3Completed
- Sponsor
- United Lincolnshire Teaching Hospitals NHS Trust
- Start
- Jul 2000
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, open-label trial of docetaxel in breast cancer (2 arms), sponsored by United Lincolnshire Teaching Hospitals NHS Trust. Primary endpoint: Quality of life. Started Jul 2000; status: completed.
02
Drugs
docetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on ISRCTN09184069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN09184069.